Cargando…

Sichere R0-Resektion zur Vermeidung der adjuvanten Therapieeskalation beim Oropharynxkarzinom

BACKGROUND: Resection margins in patients with oropharyngeal squamous cell carcinoma (OPSCC) are a predictive marker for overall survival (OS) and recurrence-free interval (RFI). Adjuvant therapy is influenced by TNM status, extracapsular extension (ECE), and resection margin status (R) of the prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansour, N., Backes, C., Becker, C., Hofauer, B., Knopf, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997822/
https://www.ncbi.nlm.nih.gov/pubmed/32975607
http://dx.doi.org/10.1007/s00106-020-00932-y
_version_ 1783670412167610368
author Mansour, N.
Backes, C.
Becker, C.
Hofauer, B.
Knopf, A.
author_facet Mansour, N.
Backes, C.
Becker, C.
Hofauer, B.
Knopf, A.
author_sort Mansour, N.
collection PubMed
description BACKGROUND: Resection margins in patients with oropharyngeal squamous cell carcinoma (OPSCC) are a predictive marker for overall survival (OS) and recurrence-free interval (RFI). Adjuvant therapy is influenced by TNM status, extracapsular extension (ECE), and resection margin status (R) of the primary tumor. The R status can be directly influenced by the head and neck surgeon. The aim of the current study was to evaluate the impact of R status on treatment decisions, RFI, and OS. MATERIALS AND METHODS: All patients with OPSCC who underwent surgery (with/without adjuvant therapy) between 2001 and 2011 were enrolled. Clinical data, survival parameters, histologic data such as ECE, resection margin status, and tumor size were retrospectively collected and analyzed. RESULTS: A total of 208 patients were enrolled. Survival parameters showed that patients with microscopically clear (R0) resection margins had an RFI/OS of 89/87 months. These values decreased in patients with R1 (65/65 months), R2 (38/33 months), and Rx (unclear) resections (59/45 months; p =  0.036/p = 0.001). In patients with ECE and R1 resection, but also in those with R0 resections achieved by follow-up resection and those with Rx resections, adjuvant therapy was escalated. CONCLUSION: Unclear resection status reduces OS and RFI in patients with OPSCC. Therefore, in surgical therapy, clear resection status in the first pass should be strived for to avoid escalation of adjuvant therapy due to an unclear R status.
format Online
Article
Text
id pubmed-7997822
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-79978222021-04-16 Sichere R0-Resektion zur Vermeidung der adjuvanten Therapieeskalation beim Oropharynxkarzinom Mansour, N. Backes, C. Becker, C. Hofauer, B. Knopf, A. HNO Originalien BACKGROUND: Resection margins in patients with oropharyngeal squamous cell carcinoma (OPSCC) are a predictive marker for overall survival (OS) and recurrence-free interval (RFI). Adjuvant therapy is influenced by TNM status, extracapsular extension (ECE), and resection margin status (R) of the primary tumor. The R status can be directly influenced by the head and neck surgeon. The aim of the current study was to evaluate the impact of R status on treatment decisions, RFI, and OS. MATERIALS AND METHODS: All patients with OPSCC who underwent surgery (with/without adjuvant therapy) between 2001 and 2011 were enrolled. Clinical data, survival parameters, histologic data such as ECE, resection margin status, and tumor size were retrospectively collected and analyzed. RESULTS: A total of 208 patients were enrolled. Survival parameters showed that patients with microscopically clear (R0) resection margins had an RFI/OS of 89/87 months. These values decreased in patients with R1 (65/65 months), R2 (38/33 months), and Rx (unclear) resections (59/45 months; p =  0.036/p = 0.001). In patients with ECE and R1 resection, but also in those with R0 resections achieved by follow-up resection and those with Rx resections, adjuvant therapy was escalated. CONCLUSION: Unclear resection status reduces OS and RFI in patients with OPSCC. Therefore, in surgical therapy, clear resection status in the first pass should be strived for to avoid escalation of adjuvant therapy due to an unclear R status. Springer Medizin 2020-09-25 2021 /pmc/articles/PMC7997822/ /pubmed/32975607 http://dx.doi.org/10.1007/s00106-020-00932-y Text en © The Author(s) 2020 Open Access. Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de.
spellingShingle Originalien
Mansour, N.
Backes, C.
Becker, C.
Hofauer, B.
Knopf, A.
Sichere R0-Resektion zur Vermeidung der adjuvanten Therapieeskalation beim Oropharynxkarzinom
title Sichere R0-Resektion zur Vermeidung der adjuvanten Therapieeskalation beim Oropharynxkarzinom
title_full Sichere R0-Resektion zur Vermeidung der adjuvanten Therapieeskalation beim Oropharynxkarzinom
title_fullStr Sichere R0-Resektion zur Vermeidung der adjuvanten Therapieeskalation beim Oropharynxkarzinom
title_full_unstemmed Sichere R0-Resektion zur Vermeidung der adjuvanten Therapieeskalation beim Oropharynxkarzinom
title_short Sichere R0-Resektion zur Vermeidung der adjuvanten Therapieeskalation beim Oropharynxkarzinom
title_sort sichere r0-resektion zur vermeidung der adjuvanten therapieeskalation beim oropharynxkarzinom
topic Originalien
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997822/
https://www.ncbi.nlm.nih.gov/pubmed/32975607
http://dx.doi.org/10.1007/s00106-020-00932-y
work_keys_str_mv AT mansourn sicherer0resektionzurvermeidungderadjuvantentherapieeskalationbeimoropharynxkarzinom
AT backesc sicherer0resektionzurvermeidungderadjuvantentherapieeskalationbeimoropharynxkarzinom
AT beckerc sicherer0resektionzurvermeidungderadjuvantentherapieeskalationbeimoropharynxkarzinom
AT hofauerb sicherer0resektionzurvermeidungderadjuvantentherapieeskalationbeimoropharynxkarzinom
AT knopfa sicherer0resektionzurvermeidungderadjuvantentherapieeskalationbeimoropharynxkarzinom